Business Context and Reporting Period
Company: NeuroOne Medical Technologies Corp (NMTC)
Filing Type: Form 8-K (Current Report)
Date of Report: November 7, 2024
Reporting Period: Event date November 7, 2024
Key Financial Metrics
This filing reports a specific corporate event rather than periodic financial performance. Consequently, the document does not provide data on revenue, profit, cash flow, margins, or liquidity ratios.
Debt Status: As of the termination date, the Company had no loan balance outstanding under the terminated agreement.
Material Changes
- Termination of Material Definitive Agreement: On November 7, 2024, NeuroOne and Growth Opportunity Funding, LLC mutually agreed to terminate the Loan and Security Agreement dated August 2, 2024.
- Outstanding Balance: The termination occurred with zero outstanding loan balance.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of new risks or contingencies beyond the termination of the specific loan agreement. The terms of the original agreement are referenced from a prior 8-K filed on August 7, 2024.
Investor Verification Checklist
- Verify the terms of the original Loan Agreement referenced in the August 7, 2024, Form 8-K.
- Confirm the absence of any remaining obligations or fees associated with the terminated loan.
- Review subsequent filings for updates on the company's overall liquidity and capital resources.